Due to cerulenin’s ability to inhibit fatty acid synthase (FAS) that, in turn, decreases the expression of ErbB1, 2, and 4, it may initiate an epithelial-to-mesenchymal transition (EMT) as well as the migration and invasive ability of cancer cells [100]. The gene discussed is EGFR; the disease is cancer.